posted on 2020-07-16, 09:22authored byFurtado G Eustáquio, Chupel M Uba, Minuzzi L Guerra, Rama Luis, Colado J Carlos, Eef HogervorstEef Hogervorst, Ferreira J Pedro, Teixeira A Maria
Background:
Frail individuals experience an accelerated immunosenescence, and exercise has been
identified as a therapy to promote a better inflammatory environment.
Objective:
To analyze the effects of 28-weeks of two different exercise protocols on the functional fitness and
immune profiles of institutionalized pre-frail and frail women with mild cognitive impairment.
Methods:
Participants residing in care homes (n=60, 81±7.84 years old) were randomized into three groups: a
chair elastic band muscle-strength exercise (CSE, n=21; 81±4.79), a chair multimodal exercise (CME, n=20;
80±8.19), and a control non-exercise (CGne, n=19; 80±10.01). Both CME and CSE groups performed
progressive circuit-training exercise sessions. The controls did not change their usual lifestyle. The Fried protocol
and the Mini-Mental State Examination questionnaire were used to identify the frail subgroups and the
participants with mild cognitive impairment. Data for anti and pro-inflammatory markers and physical fitness
were analyzed pre and post-interventions.
Results:
After the intervention, a significant effect of time and time by group for sIgA and time by group for IL-
10 levels were found (p > 0.05). Within-group analysis showed a significant moderate decrease in the TNF-α to
IL-10 ratio for the CME group and an increase in the controls (p > 0.05) and a slight reduction in the IL-6 and IL-
1β concentrations. The controls showed a negative trend towards a decrease in physical fitness and a trend for
increased levels in the pro-inflammatory markers IL-6 and IL-1β.
Conclusions:
The evidence regarding the use of systematic and moderate long-term exercise as therapy for
promoting a better balance between pro- and anti-inflammatory environments and a decrease in the inflammatory
index for the CME group were the most promising results from this study.
This paper was accepted for publication in the journal Current Pharmaceutical Design and the definitive published version is available at https://doi.org/10.2174/1381612826666200203123258